Trial · NCT00649792
Adverse events74
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 74
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Adverse Drug Reaction | General disorders | Fampridine-SR | 18 | 214 | 24 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Fampridine-SR | 33 | 214 | 43 |
| other | Asthenia | General disorders | Fampridine-SR | 12 | 214 | 14 |
| other | Back Pain | Musculoskeletal and connective tissue disorders | Fampridine-SR | 23 | 214 | 30 |
| other | Balance Disorder | Nervous system disorders | Fampridine-SR | 23 | 214 | 29 |
| other | Blood Creatine Phosphokinase Increased | Investigations | Fampridine-SR | 13 | 214 | 15 |
| other | Contusion | Injury, poisoning and procedural complications | Fampridine-SR | 30 | 214 | 40 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Fampridine-SR | 11 | 214 | 11 |
| other | Depression | Psychiatric disorders | Fampridine-SR | 14 | 214 | 19 |
| other | Dizziness | Nervous system disorders | Fampridine-SR | 24 | 214 | 30 |
| other | Fall | Injury, poisoning and procedural complications | Fampridine-SR | 88 | 214 | 182 |
| other | Fatique | General disorders | Fampridine-SR | 37 | 214 | 39 |
| other | Headache | Nervous system disorders | Fampridine-SR | 15 | 214 | 21 |
| other | Hypoaesthesia | Nervous system disorders | Fampridine-SR | 13 | 214 | 13 |
| other | Influenza | Infections and infestations | Fampridine-SR | 15 | 214 | 17 |
| other | Insomnia | Psychiatric disorders | Fampridine-SR | 16 | 214 | 18 |
| other | Multiple Sclerosis Relapse | Nervous system disorders | Fampridine-SR | 61 | 214 | 102 |
| other | Muscle Spasms | Musculoskeletal and connective tissue disorders | Fampridine-SR | 14 | 214 | 14 |
| other | Muscle Spasticity | Nervous system disorders | Fampridine-SR | 29 | 214 | 33 |
| other | Muscular Weakness | Musculoskeletal and connective tissue disorders | Fampridine-SR | 38 | 214 | 48 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00649792/events